Spots Global Cancer Trial Database for Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance
Official Title: The Impact of Antioxidants on MRI Markers of Cell Proliferation and Hypoxia Among Men on Active Surveillance With Early Stage Prostate Cancer
Study ID: NCT00744549
Study Description
Brief Summary: The purpose of this study is to determine whether antioxidants (vitamin E, selenium and lycopene)can change(reduce)prostate tumor size or blood flow to the prostate as determined by MRI imaging among men on Active Surveillance.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
University Health Network - Princess Margaret Hospital, Toronto, Ontario, Canada
Contact Details
Name: Neil Fleshner
Affiliation: Princess Margaret Hospital, Canada
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
